In the future, in addition to the financial statements bulletin and half-year report, Bioretec will also publish business reviews for January-March and January-September. As a result,
The updated disclosure policy is available on the company's web pages at https://bioretec.com/investors/investors-in-english/investor-relations/disclosure-policy
In 2024, Bioretec will publish the following financial reports:
- financial statements bulletin for January-
December 2023 on Friday16 February 2024 -
Annual Report for 2023 during week 11/2024 at the latest (week commencing on
11 March 2024 ) -
business review for January-
March 2024 on Thursday16 May 2024 -
half-year report for January-
June 2024 on Thursday15 August 2024 -
business review for January-
September 2024 on Thursday14 November 2024
The Annual Report includes the report of the Board of Directors, the consolidated financial statements, the parent company financial statements, and the auditor's report for the financial period 1 January-
The releases will be available online at
Further enquiries
Certified adviser
Information about Bioretec
Bioretec is a globally operating Finnish medical device company that continues to pioneer the application of biodegradable orthopedic implants. The company has built unique competencies in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The products developed and manufactured by Bioretec are used worldwide in approximately 40 countries.
Bioretec is developing the new RemeOs(TM) product line based on a magnesium alloy and hybrid composite, introducing a new generation of strong biodegradable materials for enhanced surgical outcomes. The RemeOs(TM) implants are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The combination has the potential to make titanium implants redundant and help clinics reach their
Better healing - Better life. www.bioretec.com
https://news.cision.com/bioretec/r/bioretec-ltd-s-schedule-for-financial-reporting-in-2024-and-updates-in-the-disclosure-policy,c3891649
(c) 2023 Cision. All rights reserved., source